{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:56:52Z","timestamp":1758819412711},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.transproceed.2005.03.114","type":"journal-article","created":{"date-parts":[[2005,6,20]],"date-time":"2005-06-20T20:04:21Z","timestamp":1119297861000},"page":"2257-2260","source":"Crossref","is-referenced-by-count":5,"title":["CD4\u2212veCD8\u2212ve CD30+ve T Cells Are Detectable in Human Lung Transplant Patients and Their Proportion of the Lymphocyte Population After In Vitro Stimulation With Donor Spleen Cells Correlates With Preservation of Lung Physiology"],"prefix":"10.1016","volume":"37","author":[{"given":"K.","family":"Polster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Fildes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Entwistle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Yonan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.V.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.T.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2005.03.114_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1164\/ajrccm.155.3.9117010","article-title":"State of the art","volume":"155","author":"Trulock","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.transproceed.2005.03.114_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0272-5231(05)70382-8","article-title":"Obliterative bronchiolitis","volume":"18","author":"Kelly","year":"1997","journal-title":"Clinics Chest Med"},{"key":"10.1016\/j.transproceed.2005.03.114_bib3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/77513","article-title":"Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression","volume":"6","author":"Zhang","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.transproceed.2005.03.114_bib4","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.4049\/jimmunol.165.9.5105","article-title":"CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis","volume":"165","author":"Muta","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2005.03.114_bib5","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.4049\/jimmunol.153.7.2861","article-title":"CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity","volume":"153","author":"Alzona","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2005.03.114_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/18692","article-title":"Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cells","volume":"398","author":"Kurts","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2005.03.114_bib7","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00007890-199805150-00016","article-title":"CD30 expression identifies a functional alloreactive human T-lymphocyte subset","volume":"65","author":"Martinez","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.03.114_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.1999.tb01303.x","article-title":"CD30 prevents T-cell responses to non-lymphoid tissues","volume":"169","author":"Heath","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.transproceed.2005.03.114_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jlb.57.5.726","article-title":"CD30 and type 2 T helper (Th2) responses","volume":"57","author":"Romagnani","year":"1995","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.transproceed.2005.03.114_bib10","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1097\/01.ASN.0000014256.75920.5B","article-title":"Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30","volume":"13","author":"Susal","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2005.03.114_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00007890-200201150-00002","article-title":"Soluble CD30 as a predictor of kidney graft outcome","volume":"73","author":"Pelzl","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.03.114_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0041-1345(98)01735-7","article-title":"CD30+ and CD27\u2212 lymphocytes in liver transplant. Th2 cytokine secretion","volume":"31","author":"Minguela","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2005.03.114_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0041-1345(00)01943-6","article-title":"The role of CD30 in skin and heart allograft rejection in the mouse","volume":"33","author":"Beckman","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2005.03.114_bib14","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4049\/jimmunol.163.1.194","article-title":"CD30 overexpression enhances negative selection in the thymus and mediates programmed cell death via a Bcl-2-sensitive pathway","volume":"163","author":"Chiarle","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.transproceed.2005.03.114_bib15","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.4049\/jimmunol.165.11.6170","article-title":"The TNF receptor family member CD30 is not essential for negative selection","volume":"165","author":"DeYoung","year":"2000","journal-title":"J Immunol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113450500357X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113450500357X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:07:02Z","timestamp":1683119222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113450500357X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S004113450500357X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2005.03.114","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}